Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilya Demchenko

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Affective Disorders|December 18, 2021
Baseline anxiety, and early anxiety/depression improvement in anxious depression predicts treatment outcomes with escitalopram: A CAN-BIND-1 study reportYuelee Khoo, Ilya Demchenko, Benicio N Frey, et al.
Frontiers in Neuroscience|September 13, 2024
Target engagement of the subgenual anterior cingulate cortex with transcranial temporal interference stimulation in major depressive disorder: a protocol for a randomized sham-controlled trialIlya Demchenko, Sumientra Rampersad, Abhishek Datta, et al.
Journal of Affective Disorders|December 23, 2021
Dorsomedial prefrontal rTMS for depression in borderline personality disorder: A pilot randomized crossover trialKfir Feffer, Hyewon Helen Lee, Wei Wu, et al.
Psychiatry Research|May 10, 2023
The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 reportManish Dama, Michelle Wu, Vanessa K Tassone, et al.
The Journal of ECT|September 14, 2021
Electroconvulsive Therapy in Canada During the First Wave of COVID-19: Results of the "What Happened" National SurveyIlya Demchenko, Daniel M Blumberger, Alastair J Flint, et al.
Journal of Neuroscience Methods|April 3, 2026
EEG-AI: An Agentic System for AI-Assisted Semi-Automated EEG Preprocessing and Artifact RemovalAbdelrahman Abdou, Martin Ivanov, Sarmed Shaya, et al.
Journal of Psychopharmacology (Oxford, England)|May 12, 2022
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study reportCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Brain and Behavior|March 25, 2022
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapyCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 21, 2026
Subgenual anterior cingulate cortex and antidepressant response to serotonergic and glutamatergic pharmacological treatments: a systematic review of neuroimaging studiesRachel L Sousa-Ho, Ilya Demchenko, Vanessa A Baltazar, et al.
BMJ Mental Health|February 28, 2025
Lack of neuropsychological effects following short-term subcallosal cingulate gyrus deep brain stimulation in treatment-resistant depression: a randomised crossover studyFatemeh Gholamali Nezhad, Vanessa K Tassone, Yuelee Khoo, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Affective Disorders|December 18, 2021
Baseline anxiety, and early anxiety/depression improvement in anxious depression predicts treatment outcomes with escitalopram: A CAN-BIND-1 study reportYuelee Khoo, Ilya Demchenko, Benicio N Frey, et al.
Frontiers in Neuroscience|September 13, 2024
Target engagement of the subgenual anterior cingulate cortex with transcranial temporal interference stimulation in major depressive disorder: a protocol for a randomized sham-controlled trialIlya Demchenko, Sumientra Rampersad, Abhishek Datta, et al.
Journal of Affective Disorders|December 23, 2021
Dorsomedial prefrontal rTMS for depression in borderline personality disorder: A pilot randomized crossover trialKfir Feffer, Hyewon Helen Lee, Wei Wu, et al.
Psychiatry Research|May 10, 2023
The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 reportManish Dama, Michelle Wu, Vanessa K Tassone, et al.
The Journal of ECT|September 14, 2021
Electroconvulsive Therapy in Canada During the First Wave of COVID-19: Results of the "What Happened" National SurveyIlya Demchenko, Daniel M Blumberger, Alastair J Flint, et al.
Journal of Neuroscience Methods|April 3, 2026
EEG-AI: An Agentic System for AI-Assisted Semi-Automated EEG Preprocessing and Artifact RemovalAbdelrahman Abdou, Martin Ivanov, Sarmed Shaya, et al.
Journal of Psychopharmacology (Oxford, England)|May 12, 2022
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study reportCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Brain and Behavior|March 25, 2022
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapyCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 21, 2026
Subgenual anterior cingulate cortex and antidepressant response to serotonergic and glutamatergic pharmacological treatments: a systematic review of neuroimaging studiesRachel L Sousa-Ho, Ilya Demchenko, Vanessa A Baltazar, et al.
BMJ Mental Health|February 28, 2025
Lack of neuropsychological effects following short-term subcallosal cingulate gyrus deep brain stimulation in treatment-resistant depression: a randomised crossover studyFatemeh Gholamali Nezhad, Vanessa K Tassone, Yuelee Khoo, et al.
Pageof 4